Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsInventoryLiabilities and Shareholders EquityNon-Current AssetsNotes PayablesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsReceivablesReceivables - DoubtfulRetained EarningsShareholder's EquityShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICU) Cash & Equivalents (2023 - 2025)

SeaStar Medical Holding (ICU) has disclosed Cash & Equivalents for 3 consecutive years, with $13.8 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Cash & Equivalents rose 561.05% year-over-year to $13.8 million, compared with a TTM value of $13.8 million through Sep 2025, up 561.05%, and an annual FY2024 reading of $1.8 million, up 933.52% over the prior year.
  • Cash & Equivalents was $13.8 million for Q3 2025 at SeaStar Medical Holding, up from $6.3 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $13.8 million in Q3 2025 and bottomed at $13000.0 in Q2 2023.
  • Average Cash & Equivalents over 3 years is $3.3 million, with a median of $1.8 million recorded in 2024.
  • The sharpest move saw Cash & Equivalents soared 8969.23% in 2024, then rose 5.6% in 2025.
  • Year by year, Cash & Equivalents stood at $176000.0 in 2023, then surged by 933.52% to $1.8 million in 2024, then soared by 656.62% to $13.8 million in 2025.
  • Business Quant data shows Cash & Equivalents for ICU at $13.8 million in Q3 2025, $6.3 million in Q2 2025, and $5.3 million in Q1 2025.